| Name | Market | Market CAP | Share price | Daily share movement |
|---|---|---|---|---|
| Advanced Medical Solutions Group | AIM | £493.97 m | 229.25 GBX | -1.61% |
| Advanced Micro Devices, Inc. | NASDAQ | $102.58 billion | 84.13 USD | -2.62% |
| Advanced Nano Technologies Ltd | ASX | $237.55 m | 3.96 AUD | 0.00% |
| Advanced Oncotherapy PLC | LSE | £139.62 m | 40.00 GBX | -2.44% |
| Advanced Oxygen Technologies, Inc. | PINK | $477.48 k | 0.15 USD | -26.40% |
| Advanced Photonix, Inc. | NYSE | $6.02 billion | 60.66 USD | -7.98% |
| Advanced Proteome Therapeutics Corp. | TSX-V | $7.26 m | 0.26 CAD | 4.00% |
| Advanced Share Registry Limited | ASX | $36.53 m | 0.85 AUD | -3.41% |
| Advanced Vision Technology | FRA | 0.00 | 0.00% | |
| Advanced Voice Recognition Systems, Inc. | PINK | $5.04 m | 0.02 USD | 0.00% |
| AdvanSource Biomaterials Corp. | OTCQB | $1.13 m | 0.04 USD | 25.00% |
| Advant-e Corp. | PINK | $29.9 m | 5.01 USD | -5.47% |
| Advantage Lithium Corp. | TSX-V | $43.14 m | 0.27 CAD | -3.64% |
| Advantage Oil & Gas Ltd. | TSX | $479.69 m | 2.55 CAD | -0.78% |
| Advantaged CDN High Yield Bond Fund | TSX | $15.92 m | 7.31 CAD | -0.27% |
| Advantest | NYSE | 0.00 | 0.00% | |
| Advaxis | NASDAQ | $91.26 m | 0.83 USD | -5.93% |
| Advent Software, Inc. | NASDAQ | 0.00 | 0.00% | |
| Adventure Gold Inc | TSX-V | $0.00 | 0.00 CAD | 0.00% |
| ADVENTUS ZINC CORPORATION | TSX-V | $112.74 m | 0.86 CAD | -4.44% |
| Adveritas Ltd | ASX | $60.68 m | 0.17 AUD | 0.00% |
| Adverum Biotechnlogies Inc | NASDAQ | $1.18 billion | 12.15 USD | -8.78% |
| ADVFN | AIM | £9 m | 35.00 GBX | 4.48% |
| AdvisorShares ETF | NYSEMKT | $441.12 m | 25.91 USD | -5.20% |
| ADX Energy Limited | ASX | $22.38 m | 0.01 AUD | 0.00% |
| AECOM Technology | NYSE | $8.52 billion | 57.68 USD | -1.60% |
| Aecon Group | TSX | $1.13 billion | 18.80 CAD | -2.34% |
| Aeeris Ltd | ASX | $7.5 m | 0.13 AUD | 19.05% |
| AEGEAN Airlines | PINK | $368.51 m | 5.16 USD | -13.57% |
| Aegle Therapeutics Corp | Unlisted | 0.00 | 0.00% | |
| Aeglea Biotherapeutics | NASDAQ | $371.51 m | 7.75 USD | -0.51% |
| Aehr Test Systems | NASDAQ | $68.6 m | 2.92 USD | -5.50% |
| Aemetis Inc | NASDAQ | $399.01 m | 16.97 USD | 13.66% |
| Aeolus Pharmaceuticals, Inc. | PINK | $1.6 m | 0.01 USD | 2.44% |
| AEON Biopharma | Unlisted | 0.00 | 0.00% | |
| Aeon Metals Ltd | ASX | $77.92 m | 0.12 AUD | 9.52% |
| Aeorema Communications | AIM | £2.59 m | 28.00 GBX | 0.00% |
| AEP Industries | NASDAQ | 0.00 | 0.00% | |
| Aequus Pharmaceuticals Inc. | TSX-V | $30.22 m | 0.27 CAD | -3.57% |
| AER Lingus Group plc | LSE | 0.00 | 0.00% |